Nothing Special   »   [go: up one dir, main page]

Takacs et al., 1984 - Google Patents

Detection and localization by the monoclonal antiinterleukin 2 receptor antibody AMT‐13 of IL 2 receptor‐bearing cells in the developing thymus of the mouse embryo …

Takacs et al., 1984

Document ID
5749864278409306556
Author
Takacs L
Osawa H
Diamantstein T
Publication year
Publication venue
European journal of immunology

External Links

Snippet

During embryonic development of the mouse, before expressing classical T cell markers, the blast cells colonizing the thymus react with the monoclonal antibody AMT‐13 shown previously to detect interleukin 2 receptors. The proportion of AMT‐13+ cells decreases as …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay

Similar Documents

Publication Publication Date Title
Takacs et al. Detection and localization by the monoclonal antiinterleukin 2 receptor antibody AMT‐13 of IL 2 receptor‐bearing cells in the developing thymus of the mouse embryo and in the thymus of cortisone‐treated mice
CA2210751C (en) Anti-cd6 monoclonal antibodies and their uses
Clevers et al. Identification of a bovine surface antigen uniquely expressed on CD4− CD8− T cell receptor γ/δ+ T lymphocytes
Jefferies et al. Analysis of lymphopoietic stem cells with a monoclonal antibody to the rat transferrin receptor.
Kiessling et al. Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems.
Touraine et al. Differentiation of human bone marrow cells into T lymphocytes by in vitro incubation with thymic extracts
Bodger et al. A monoclonal antibody specific for immature human hemopoietic cells and T lineage cells.
Raghavachar et al. T lymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome.
Konishi et al. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.
Bulmer et al. Depletion of circulating T lymphocytes in pregnancy.
DE69406664T2 (en) COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODY AGAINST CD44V6
Lobach et al. The human thymic microenvironment. Phenotypic characterization of Hassall's bodies with the use of monoclonal antibodies.
Paige et al. Differentiation of murine B cell precursors in agar culture. Frequency, surface marker analysis and requirements for growth of clonable pre‐B cells
EP0025722B2 (en) Monoclonal antibody to human cytotoxic and suppressor T cells, and method of preparing it
Aiuti et al. Effect of thymus factor on human precursor T lymphocytes
Jully et al. Immunohistological identification of cell subsets in human gingival after local treatment for gingivitis or periodontitis
Gruschwitz et al. Phenotypic analysis of skin infiltrates in comparison with peripheral blood lymphocytes, spleen cells and thymocytes in early avian scleroderma
Ebert Sheep red blood cells enhance T-lymphocyte proliferation
Preud'Homme et al. Immunoglobulin D-bearing lymphocytes in primary immunodeficiencies
Moutsopoulos et al. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
Peter et al. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control persons
Hofman et al. Distribution of cells bearing the Tac antigen during ontogeny of human lymphoid tissue.
Natali et al. Ontogeny of human Ia antigens
Lesley et al. Thy-1 antigen expression on rat brain cell lines
Bene et al. In vitro induction of monoclonal antibody-defined T-cell markers in lymphocytes from immunodeficient children by synthetic serum thymic factor (FTS).